INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) shares fell 4.5% on Monday . The stock traded as low as $0.81 and last traded at $0.81. 19,996 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 1,587,563 shares. The stock had previously closed at $0.85.
INVO Bioscience Stock Down 4.5 %
The company’s fifty day moving average price is $0.79 and its two-hundred day moving average price is $0.83.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC. purchased a new position in shares of INVO Bioscience, Inc. (NASDAQ:INVO – Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned approximately 2.64% of INVO Bioscience as of its most recent SEC filing. Hedge funds and other institutional investors own 12.02% of the company’s stock.
INVO Bioscience Company Profile
INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
See Also
- Five stocks we like better than INVO Bioscience
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Applied Materials Market Capitulates: Now is the Time to Buy
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for INVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.